BMS and AbbVie get FDA lift
May 21, 2014Research and Development, Sales and Marketing AbbVie, BMS, FDA, elotuzumab, multiple, myeloma
Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …
Gilead price lambasted by US health insurers
May 21, 2014Medical Communications, Sales and Marketing Gilead, Incivek, Victrelis, hepatitis C, sovaldi
Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …
Rebranding and personnel news for Discovery London
May 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing holy, london discovery, medics, publicis
Publicis Healthcare-owned med comms firm Medicus International has been rebranded as Discovery London. Barbara Joly is the general manager of …
GAVI vaccine group call for $7.5 billion funding
May 20, 2014Medical Communications, Sales and Marketing GAVI Alliance, Vaccine, WHO, rotavirus vaccine
The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …
Medicus International rebrands as Discovery London
May 20, 2014Medical Communications, Sales and Marketing Medicus International, Publicis Healthcare
Publicis Healthcare-owned medical communications group Medicus International has rebranded to Discovery London, thereby officially joining the Discovery worldwide brand. Discovery …
Europe approves Janssen’s hep C drug Olysio
May 20, 2014Research and Development, Sales and Marketing Janssen, hepatitis C, sovaldi
Janssen-Cilag International’s Olysio has been given marketing authorisation in the European Union for the treatment of adults with hepatitis C …
Abbott makes Latin America move
May 20, 2014Manufacturing and Production, Sales and Marketing AbbVie, Abbott, CFR, Chile, pharmerging
Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …
Boehringer and InterMune data on IPF drugs impress
May 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, InterMune, idiopathic pulmonary fibrosis
Two new medicines for a generally fatal lung disease, known as idiopathic pulmonary fibrosis and made by Boehringer and InterMune, …
Braille phone launched by UK developer
May 19, 2014Manufacturing and Production, Medical Communications, Research and Development Apple
British technology firm OwnFone has launched what it says is the first commercially available Braille phone. The device, which shares …
Novartis agrees Gleevec patent deal
May 19, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent
Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …
AstraZeneca rejects Pfizer’s ‘final offer’
May 19, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover
AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …
Science left behind in Pfizer-AstraZeneca saga
May 18, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, Wellcome Trust, science
With all the posturing, debates and endless comment on the commercial aspects of a $106 billion deal between Pfizer and …
Pfizer to submit breast cancer drug
May 18, 2014Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib
Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …
Merck sells Colorado biologics plant to KBI
May 18, 2014Manufacturing and Production KBI, Merck, manufacturing
Merck & Co has swung the axe over its M&P operations again – this time for its biologics plant in …
Clinical evidence revisited
May 18, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Lord Saatchi, Medical Innovation Bill, clinical trials
One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …
Heartbreak for Novartis as FDA rejects drug
May 18, 2014Research and Development, Sales and Marketing GSK, Novartis, heart drug
Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …
AstraZeneca signs UK research deal
May 16, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, Pfizer
The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
